If you liked this article you might like

Jim Cramer's 'Mad Money' Recap: The Urge to Merge Rules Wall Street
Portfolio Manager: Is Pfizer Acquiring Too Quickly?
Pfizer Is Buying a Portion of AstraZeneca's Antibiotics Business
Why Pfizer's Latest Deal Could Send Its Shares Soaring